Survival benefits from adjuvant transcatheter arterial chemoembolization in patients undergoing liver resection for hepatocellular carcinoma: a systematic review and meta-analysis.

Lei LiangChao LiYong-Kang DiaoHang-Dong JiaHao XingTimothy M PawlikWan Yee LauFeng ShenDong-Sheng HuangCheng-Wu ZhangTian Yang

Published in: Therapeutic advances in gastroenterology (2020)

Postoperative adjuvant TACE may be effective to improve OS and DFS in patients with multinodular HCC, or HCC with MVI or PVTT. Future randomized controlled trials are needed to better define the benefit of adjuvant TACE in subset patients with HCC.

Keyphrases

patients undergoing
early stage
randomized controlled trial
current status
clinical trial
radiofrequency ablation